Form 4 for TYRA Tyra Biosciences, Inc.

Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-17 · accession 0000899243-21-036424 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-09-17	2021-09-17	TYRA	CHEN ISAN	Dir	C - Cnv Deriv	—	+61.4K	192.8K	+47%	—
DM	2021-09-17	2021-09-17	TYRA	CHEN ISAN	Dir	C - Cnv Deriv	$0.00	-23.7K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-09-17	C	A	61,444	—	192,783	D	—	—	(F1) On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. (F2) Includes 37,105 shares subject to repurchase by us, which are subject to vesting.
2	Derivative	Series B Preferred Stock	2021-09-17	C	D	7,290	$0.00	0	D	— · — to —	18,935 Common Stock	(F1) On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
3	Derivative	Series A Preferred Stock	2021-09-17	C	D	16,366	$0.00	0	D	— · — to —	42,509 Common Stock	(F1) On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.